Managing benzodiazepine withdrawal during pregnancy: case-based guidelines

Substance use disorders during pregnancy pose serious risks for both the mother and the fetus, demanding careful monitoring by the patient’s medical providers. Sedative-hypnotic use, in particular, is common but remains poorly studied. Management of withdrawal from chronic benzodiazepine use during...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of women's mental health 2014-04, Vol.17 (2), p.167-170
Hauptverfasser:	Gopalan, Priya, Glance, Jody B., Azzam, Pierre N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Benzodiazepines - adverse effects Case Report Complications and side effects Development and progression Drug addiction Female Health aspects Humans Hypnotics and Sedatives - adverse effects Lorazepam Medicine Medicine & Public Health Patient outcomes Practice Guidelines as Topic Pregnancy Pregnancy Outcome Pregnant women Psychiatry Psychotherapy Psychotropic drugs Risk factors Substance abuse Substance abuse treatment Substance Withdrawal Syndrome - drug therapy Substance Withdrawal Syndrome - therapy Substance-Related Disorders - therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Substance use disorders during pregnancy pose serious risks for both the mother and the fetus, demanding careful monitoring by the patient’s medical providers. Sedative-hypnotic use, in particular, is common but remains poorly studied. Management of withdrawal from chronic benzodiazepine use during pregnancy presents unique challenges to the treating physician. We present two pregnant patients with dependence on sedative-hypnotic agents, outline principles of benzodiazepine withdrawal, and suggest guidelines for detoxification during pregnancy.
ISSN:	1434-1816 1435-1102
DOI:	10.1007/s00737-013-0388-1